Oppenheimer lowered the firm’s price target on Integral Ad Science (IAS) to $18 from $20 and keeps an Outperform rating on the shares following press reports of a potential sale of the company. After a stronger Q2, the company is experiencing headwinds in the second half of the year and guiding Q4 6%/7% below estimates, Oppenheimer adds.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IAS: